Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,774 | -2,147 | -15,666 | -12,350 | -12,217 |
| Depreciation Amortization | 114 | 67 | 349 | 293 | 240 |
| Accounts receivable | -166 | 175 | -302 | -27 | 5 |
| Other Working Capital | -577 | 184 | -2,154 | -1,795 | -660 |
| Other Operating Activity | -968 | -127 | 4,357 | 2,749 | 4,824 |
| Operating Cash Flow | $-4,370 | $-1,847 | $-13,416 | $-11,130 | $-7,807 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,000 | 5,000 | N/A | 0 | N/A |
| PPE Investments | N/A | N/A | -11 | -11 | -10 |
| Other Investing Activity | 0 | 0 | -83 | -83 | -84 |
| Investing Cash Flow | $5,000 | $5,000 | $-94 | $-94 | $-93 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 347 | 347 | N/A |
| Debt Repayment | N/A | N/A | -3,766 | -3,766 | -3,766 |
| Common Stock Issued | N/A | N/A | 8,736 | 8,736 | 3,104 |
| Other Financing Activity | -210 | -104 | -327 | -223 | -189 |
| Financing Cash Flow | $-210 | $-104 | $4,991 | $5,094 | $-851 |
| Exchange Rate Effect | -2 | 1 | -1 | -1 | 0 |
| Beginning Cash Position | 6,675 | 6,675 | 15,195 | 15,195 | 15,195 |
| End Cash Position | 7,093 | 9,724 | 6,675 | 9,064 | 6,443 |
| Net Cash Flow | $418 | $3,049 | $-8,520 | $-6,131 | $-8,753 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,370 | -1,847 | -13,416 | -11,130 | -7,807 |
| Capital Expenditure | N/A | N/A | -11 | -11 | -10 |
| Free Cash Flow | -4,370 | -1,847 | -13,428 | -11,141 | -7,817 |